Engineered cellular carrier nanoerythrosomes as potential targeting vectors for anti-malarial drug

Main Article Content

Jaya Agnihotri
Virendra Gajbhiye
Narendra Kumar Jain


The present investigation was aimed at developing and exploring the use of nanoerythrosomes (nEs) for targeted delivery of anti-malarial drug, pyrimethamine (PMA). The formulation was prepared by the extrusion method and drug was conjugated to nEs with the help of gluteraldehyde used as a cross-linking agent. The nEs formulation was optimized for drug concentration, surface morphology, viscosity, and sedimentation volume. The drug-loaded nEs showed delayed in vitro release, good stability at 4±1°C, and controlled in vivo release. Tissue distribution studies showed higher accumulation of drug in liver (17.34±1.3 μg/ml) at 3 h in the case of nEs as compared to free drug (12.82±0.7 μg/ml). A higher amount of drug i.e. 13.14±0.9 μg/ml was found after 24 h in liver in the case of nEs as compared to free drug concentration of 9.72±0.5 μg/ml. Data showed that developed PMA-loaded nEs hold promise for targeting and controlling the release of drug and improve treatment of malaria.


Download data is not yet available.

Article Details

How to Cite
Agnihotri, J., Gajbhiye, V., & Jain, N. K. (2014). Engineered cellular carrier nanoerythrosomes as potential targeting vectors for anti-malarial drug. Asian Journal of Pharmaceutics (AJP), 4(2).


World Malaria Report. WHO Expert Committee on malaria; Geneva,

Switzerland; 2008.

Farooq U, Mahajan RC. Drug resistance in malaria. J Vector Borne Dis


Molineaux L. Malaria and mortality: Some epidemiological

considerations. Ann Trop Med Parasitol 1997;91:811-25.

Murphy SC, Breman JG. Gaps in the childhood malaria burden in Africa: Cerebral malaria, neurological sequelae, anemia, respiratory distress,hypoglycemia, and complications of pregnancy. Am J Trop Med Hyg 2001;64:57-67.

Rollo I. Resistance of Plasmodium falciparum to pyrimethamine. TransacRoyal Society Trop Med Hyg 1955; 49: 94-95.

Fullerton DS. Antimalarials. 8th ed. Wilson and Gisvold’s Text book of

Organic Medical and Pharmaceutical Chemistry. In: Doergae RF, editor.

Lippincott, Philadelphia. 1982. p. 205-6.

Jain S, Jain NK. Engineered erythrocytes as a drug delivery system.

Indian J Pharm Sci 1997;59:275-81.

Gaudreault RC, Gicquaud C, Poyet P. Nanoerythrosome as bioactive

agent carrier. US patent 5653999. Published date 5 August 1997.

DeLoach JR, Barton C. Circulating carrier erythrocytes: Slow-release

vehicle for an antileukemic drug, cytosine arabinoside. Am J Vet Res


Jain S, Jain SK, Dixit VK. Erythrocytes based delivery of isoniazid:

Preparation and in vitro characterization. Indian Drugs 1995;32:471-6.

Jain S, Jain NK. Resealed erythrocytes as drug carriers. In: Jain NK, editor. Controlled and Novel Drug Delivery. New Delhi: CBS Publishers and

Distributors; 2002. p. 256-7.

Lejeune A, Moorjani M, Gicquaud C, Lacroix J, Poyet P, Gaudreault R.

Nanoerythrosomes, a new derivative of erythrocyte ghost: Preparation

and antineoplastic potential as drug carrier for daunorubicin.

Anticancer Res 1994;14:915-9.

Talwar N, Jain NK. Erythrocytes as carriers of primaquin preparation:

Characterization and evaluation. J Control Rel 1992;20:133-42.

Talwar N, Jain NK. Erythrocytes as carriers of metronidazole: In-Vitro

characterization. Drug Dev Ind Pharm 1992;18:1799-812.

Lejeune A, Poyet P, Gaudreault RC, Gicquaud C. Nanoerythrosomes, a

new derivative of erythrocyte ghost: III. Is phagocytosis involved in the

mechanism of action? Anticancer Res 1997;17:3599-603.

Minzi OM, Massele AY, Gustafsson LL, Ericsson O. Simple and

cost-effective liquid chromatographic method for determination

of pyrimethamine in whole blood samples dried on filter paper. J

Chromatogr B Analyt Technol Biomed Life Sci 2005;814:179-83.